Redefining response in wet AMD to anti VEGF therapy based on non-OCTA versus OCTA evaluation.

Based on resulting disagreements between the two modalities on deciding the continuity of anti VEGF, we conclude that OCTA must be considered in the conventional decision making algorithm in patients with wet AMD under anti VEGF therapy.